Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

316
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
316
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

3.0K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.0K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

676
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
676
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

266
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases.

Journal of hepatology·2025
Same author

Epidural steroid injection technique.

Techniques in vascular and interventional radiology·2024
Same author

Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance.

Journal of hepatology·2024
Same author

Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi-ethnic cohort.

Journal of viral hepatitis·2023
Same author

Updates in the diagnosis and management of small-bowel tumors.

Best practice & research. Clinical gastroenterology·2023
Same author

Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies.

JHEP reports : innovation in hepatology·2023
Same journal

Correction to: Challenges in diagnosing confluent and reticulated papillomatosis: a case of atypical lesions distribution.

Oxford medical case reports·2026
Same journal

Cutaneous Rosai-Dorfman-Destombes disease: the diagnostic value of the yellow island sign.

Oxford medical case reports·2026
Same journal

Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma.

Oxford medical case reports·2026
Same journal

Neuropsychiatric-pharmacologic synergy: interaction between psychiatric polypharmacy and cancer treatment-related neurotoxicity.

Oxford medical case reports·2026
Same journal

A case of surgically treated recurrent spontaneous pneumothorax during pregnancy.

Oxford medical case reports·2026
Same journal

Vaping-associated acute respiratory distress syndrome managed with VV-ECMO: a case report.

Oxford medical case reports·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Azithromycin-induced cholestatic hepatitis.

Apostolos Koffas1,2, Iain M Murray-Lyon1, Roger Williams2

  • 1The Liver Centre, The London Clinic, London, UK.

Oxford Medical Case Reports
|June 6, 2017
PubMed
Summary
This summary is machine-generated.

Azithromycin, an antibiotic, can rarely cause cholestatic hepatitis. A 69-year-old patient recovered after stopping the drug and receiving corticosteroids.

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.9K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.5K

Related Experiment Videos

Last Updated: Mar 1, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.9K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.5K

Area of Science:

  • Hepatology
  • Pharmacology
  • Internal Medicine

Background:

  • Azithromycin is a widely prescribed antibiotic known for its broad spectrum and favorable tolerability, particularly for short treatment durations (<7 days).
  • While generally safe, rare instances of azithromycin-induced liver injury, specifically cholestatic hepatitis, have been reported in medical literature.

Observation:

  • This case study details a 69-year-old male patient with a history of significant alcohol consumption.
  • The patient presented with jaundice after completing a 3-day course of azithromycin.

Findings:

  • A transjugular liver biopsy was performed for diagnostic evaluation.
  • The patient's liver function gradually improved and normalized approximately two months after azithromycin discontinuation.
  • Treatment with a short course of corticosteroids was initiated and contributed to the recovery.

Implications:

  • This case highlights a rare but serious adverse effect of azithromycin, emphasizing the importance of considering drug-induced liver injury in patients presenting with jaundice.
  • Clinicians should be vigilant for potential hepatotoxicity even with short-term antibiotic use.
  • Prompt recognition and management, including drug cessation and supportive care, are crucial for favorable outcomes in azithromycin-induced cholestatic hepatitis.